rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

IceCure Medical Ltd. -

ICCM · Nasdaq

Health CareMedical DevicesNot moving yet

ICCM stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 80.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
8 (-6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders8-6 on the quarter
New · exited3 · 8
Reported value$469K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCnew · filed 14 Aug 202634,885$170K+34,885
Scientech Research LLCnew · filed 14 Aug 202632,696$159K+32,696
UBS Group AGreduced · filed 13 Aug 202617,093$83K-137,105−88.9%
JPMORGAN CHASE & COnew · filed 12 Aug 20265,950$31K+5,950
MORGAN STANLEYreduced · filed 13 Aug 20264,334$21K-12,666−74.5%
Kingdom Financial Group LLC.reduced · filed 7 Aug 2026533$2,590-15,467−96.7%
SBI Securities Co., Ltd.added · filed 23 Jul 2026451$2,192+442+4911.1%
BARTLETT & CO. WEALTH MANAGEMENT LLCreduced · filed 24 Jul 20268$39-242−96.8%
31 Mar 2023 – 30 Jun 2026
71114Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Meir Peleg Company insiderChief Financial Officer · last 14 Aug 20260 · 0
Merav Nir Dotan Company insiderVP, Human Resources · last 14 Aug 20260 · 0
Shad Good Company insiderVP, Sales for North America · last 14 Aug 20260 · 0
Shay Levav Company insiderChief Operating Officer · last 14 Aug 20260 · 0
Tlalit Bussi Tel-Tzure Company insiderVP, BD & Global Marketing · last 14 Aug 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202536.3%
Operating profit marginFY 2025 · to 31 Dec 2025-447%
Free cash flow marginFY 2025 · to 31 Dec 2025-432%
Return on capital employedFY 2025 · to 31 Dec 2025-167%
Debt to equityFY 2025 · to 31 Dec 20250.00×
Research spendFY 2025 · to 31 Dec 2025220%
Revenue growthFY 2025 · to 31 Dec 20252.7%
Earnings per share growthFY 2025 · to 31 Dec 2025-20.0%
Share count trendFY 2025 · to 31 Dec 202529.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$8.9M
Free cash flowFY 2025 · to 31 Dec 2025−$14.6M

Analyst forecasts

No analyst forecasts yet.